My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 176

    1.

    Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.

    Pettersson-Fernholm K, Karvonen MK, Kallio J, Forsblom CM, Koulu M, Pesonen U, Fagerudd JA, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2004 Feb;27(2):503-9.PMID: 14747236 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.

    Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MI.

    Mol Genet Metab. 2002 Mar;75(3):260-4.PMID: 11914038 [PubMed - indexed for MEDLINE]Related articles

    3.

    Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.

    Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M, Rauramaa R, Töyry J, Laakso M, Uusitupa MI.

    J Clin Endocrinol Metab. 2000 Jun;85(6):2266-9.PMID: 10852461 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.

    Karvonen MK, Valkonen VP, Lakka TA, Salonen R, Koulu M, Pesonen U, Tuomainen TP, Kauhanen J, Nyyssönen K, Lakka HM, Uusitupa MI, Salonen JT.

    Atherosclerosis. 2001 Nov;159(1):145-51.PMID: 11689216 [PubMed - indexed for MEDLINE]Related articles

    5.

    The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.

    Jaakkola U, Pesonen U, Vainio-Jylhä E, Koulu M, Pöllönen M, Kallio J.

    Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):147-52.PMID: 16705546 [PubMed - indexed for MEDLINE]Related articles

    6.

    Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.

    Ma J, Nordman S, Möllsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF.

    Eur J Endocrinol. 2007 Nov;157(5):641-5.PMID: 17984244 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.

    Ukkola O, Kesäniemi YA.

    Eur J Clin Nutr. 2007 Sep;61(9):1102-5. Epub 2007 Jan 31.PMID: 17268419 [PubMed - indexed for MEDLINE]Related articles

    8.

    Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children.

    Karvonen MK, Koulu M, Pesonen U, Uusitupa MI, Tammi A, Viikari J, Simell O, Rönnemaa T.

    J Clin Endocrinol Metab. 2000 Apr;85(4):1455-60.PMID: 10770181 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.

    Niskanen L, Voutilainen-Kaunisto R, Teräsvirta M, Karvonen MK, Valve R, Pesonen U, Laakso M, Uusitupa MI, Koulu M.

    Exp Clin Endocrinol Diabetes. 2000;108(3):235-6.PMID: 10926322 [PubMed - indexed for MEDLINE]Related articles

    10.

    The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.

    Jaakkola U, Kuusela T, Jartti T, Pesonen U, Koulu M, Vahlberg T, Kallio J.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3646-52. Epub 2005 Mar 29.PMID: 15797951 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.

    Pesonen U, Koch W, Schömig A, Kastrati A.

    J Endovasc Ther. 2003 Jun;10(3):566-72.PMID: 12932169 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.

    Jaakkola U, Koulu M, Karvonen MK, Seppälä H, Pesonen U, Vahlberg T, Kallio J.

    Exp Clin Endocrinol Diabetes. 2007 May;115(5):281-6.PMID: 17516289 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.

    Ilveskoski E, Viiri LE, Mikkelsson J, Pörsti I, Lehtimäki T, Karhunen PJ.

    Atherosclerosis. 2008 Aug;199(2):445-50. Epub 2007 Dec 4.PMID: 18054939 [PubMed - indexed for MEDLINE]Related articles

    14.

    Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.

    Salminen M, Lehtimäki T, Fan YM, Vahlberg T, Kivelä SL.

    Public Health Nutr. 2008 Nov;11(11):1156-62. Epub 2008 Feb 18.PMID: 18279562 [PubMed - indexed for MEDLINE]Related articles

    15.

    Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.

    Nordman S, Ding B, Ostenson CG, Kärvestedt L, Brismar K, Efendic S, Gu HF.

    Exp Clin Endocrinol Diabetes. 2005 May;113(5):282-7.PMID: 15926114 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Low prevalence of the Leu7/Pro polymorphism in the signal peptide of preproneuropeptide Y in the Spanish Mediterranean population]

    Portolés O, Sorlí JV, González JI, Ruiz de la Fuente S, Ramírez JB, Corella D.

    Med Clin (Barc). 2003 Mar 15;120(9):337-9. Spanish. PMID: 12646110 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.

    Järvisalo MJ, Jartti L, Karvonen MK, Pesonen U, Koulu M, Marniemi J, Hammar N, Kaprio J, Paakkunainen U, Simell O, Raitakari OT, Rönnemaa T.

    Atherosclerosis. 2003 Apr;167(2):319-26.PMID: 12818415 [PubMed - indexed for MEDLINE]Related articles

    18.

    Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study.

    Wadén J, Tikkanen H, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Lakka T, Riska M, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2005 Apr;28(4):777-82.PMID: 15793172 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.

    Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Laakso M.

    Diabetes Care. 2000 Jun;23(6):791-5.PMID: 10840998 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Acute-phase proteins among patients with type 1 diabetes.

    Gomes MB, Piccirillo LJ, Nogueira VG, Matos HJ.

    Diabetes Metab. 2003 Sep;29(4 Pt 1):405-11.PMID: 14526268 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity